Business
Microbix Appoints CEO and Chairman of its New Vaccine Joint Venture in China
Jan. 18, 2011 (Canada NewsWire Group) -- Former GSK and Merieux Executives To Lead Team in...
About this update from Microbix Biosystems Inc.
[{"type":"text","content":"\n\n\n\n Jan. 18, 2011 (Canada NewsWire Group) -- \n\n#ReleaseContent TABLE\n{\n BORDER-COLLAPSE: collapse\n}\nTR.cnwUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTR.cnwDoubleUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTR.cnwBoldUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px solid\n}\nTD.cnwUnderlinedCell\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTD.cnwDoubleUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTD.cnwBoldUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px solid\n}\n#ReleaseContent TABLE.cnwBorderedTable TD\n{\n BORDER-RIGHT: black 1px solid;\n PADDING-RIGHT: 2px;\n BORDER-TOP: black 1px solid;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n BORDER-LEFT: black 1px solid;\n PADDING-TOP: 2px;\n BORDER-BOTTOM: black 1px solid;\n BORDER-COLLAPSE: collapse\n}\n#ReleaseContent TABLE TD\n{\n PADDING-RIGHT: 2px;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n PADDING-TOP: 2px\n}\n\n\nFormer GSK and Merieux Executives To Lead Team in Building and Operating Asia's Largest Vaccine Production Facility\n\n\nTORONTO, Jan. 18 /CNW/ - Microbix Biosystems Inc. (TSX: MBX), a\n biotechnology company commercializing novel technologies for influenza\n vaccine manufacturing and livestock semen sexing, in addition to a core\n business of virology products, today named the management leaders for\n the Hunan/Microbix Joint Venture which will build and operate Asia's\n largest influenza vaccine production facility. The team will be led by\n Chris Baron, CEO, a former GSK and Novartis executive responsible for\n international vaccines.  Baron also established and led GSK's joint\n venture that is now the largest foreign vaccine manufacturer in China. \n Jacques-Francois Martin, who will be Chairman, brings 30 years of\n worldwide vaccine and pharma management experience to the China\n venture.\n\n\nThe new CEO, Chris Baron said, "I am delighted and privileged to\n participate in this exciting investment in Changsha, China. The health\n and economic benefits of influenza vaccination are extremely well\n documented globally, and I look forward to working with our partners to\n provide Hunan Province self-sufficiency with a truly world class\n vaccine. This investment will also further enhance innovation in this\n fast growing region of China." Jacques-Francois Martin, the joint\n ven...